119 related articles for article (PubMed ID: 22678239)
21. Anatomical distribution of residual cancer in patients with oesophageal squamous cell carcinoma who achieved clinically complete response after neoadjuvant chemoradiotherapy.
Chao YK; Chuang WY; Yeh CJ; Chang HK; Tseng CK
Eur J Cardiothorac Surg; 2018 Jan; 53(1):201-208. PubMed ID: 28977486
[TBL] [Abstract][Full Text] [Related]
22. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
24. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.
Thompson SK; Ruszkiewicz AR; Jamieson GG; Esterman A; Watson DI; Wijnhoven BP; Lamb PJ; Devitt PG
Ann Surg Oncol; 2008 Dec; 15(12):3447-58. PubMed ID: 18830669
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
26. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration.
Van Raemdonck D; Van Cutsem E; Menten J; Ectors N; Coosemans W; De Leyn P; Lerut T
Eur J Cardiothorac Surg; 1997 May; 11(5):828-37. PubMed ID: 9196296
[TBL] [Abstract][Full Text] [Related]
27. Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?
Situ D; Wang J; Lin P; Long H; Zhang L; Rong T; Ma G
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):45-51. PubMed ID: 23490249
[TBL] [Abstract][Full Text] [Related]
28. Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients.
Hou X; Wei JC; Fu JH; Wang X; Zhang LJ; Lin P; Yang HX
Ann Surg Oncol; 2014 Jan; 21(1):337-42. PubMed ID: 24046121
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
30. Comparisons of sixth and seventh edition of the American Joint Cancer Committee staging systems for esophageal cancer.
Yam PC; Tong D; Law S
Ann Surg Oncol; 2014 Feb; 21(2):583-8. PubMed ID: 24197762
[TBL] [Abstract][Full Text] [Related]
31. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
32. Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress.
Tait DM
Radiother Oncol; 2004 Nov; 73(2):115-7. PubMed ID: 15542157
[No Abstract] [Full Text] [Related]
33. Surgery alone in the curative treatment of localised oesophageal carcinoma.
Mariette C; Piessen G; Balon JM; Van Seuningen I; Triboulet JP
Eur J Surg Oncol; 2004 Oct; 30(8):869-76. PubMed ID: 15336734
[TBL] [Abstract][Full Text] [Related]
34. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
35. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification : impact of lymph node metastases on overall survival after esophagectomy.
Yamasaki M; Miyata H; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2014 Sep; 21(9):2850-6. PubMed ID: 24728822
[TBL] [Abstract][Full Text] [Related]
37. Ten-year survival of patients with oesophageal squamous cell carcinoma.
Hu W; Liang Y; Zhang S; Hu Y; Liu J
S Afr J Surg; 2013 May; 51(2):62-6. PubMed ID: 23725895
[TBL] [Abstract][Full Text] [Related]
38. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
[TBL] [Abstract][Full Text] [Related]
39. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma?
Liu J; Xie X; Zhou C; Peng S; Rao D; Fu J
Eur J Cardiothorac Surg; 2012 Mar; 41(3):e7-11. PubMed ID: 22219482
[TBL] [Abstract][Full Text] [Related]
40. Application of the 8th edition of the AJCC yTNM staging system shows improved prognostication in a single center cohort of esophageal carcinomas.
Kröll D; Noser L; Erdem S; Storni F; Arnold D; Dislich B; Zlobec I; Candinas D; Seiler CA; Langer R
Surg Oncol; 2018 Mar; 27(1):100-105. PubMed ID: 29549896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]